new antiepileptic, Gabitril (tiagabine)

    Abbott is launching a new antiepileptic, Gabitril (tiagabine). It'll be used as add-on therapy to control partial seizures.

    Gabitril is thought to work by blocking the reuptake of GABA...the major inhibitory neurotransmitter in the CNS. The increased GABA levels "apply the brakes" to inhibit seizures.

    Patients use different doses of Gabitril...depending on their other antiepileptic therapy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote